Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Express Scripts
Farmers Insurance
Fish and Richardson
Covington
Daiichi Sankyo
McKesson
Boehringer Ingelheim
Moodys
Julphar

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 009218

« Back to Dashboard

NDA 009218 describes COUMADIN, which is a drug marketed by Bristol Myers Squibb and is included in one NDA. It is available from six suppliers. Additional details are available on the COUMADIN profile page.

The generic ingredient in COUMADIN is warfarin sodium. There are twenty-two drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the warfarin sodium profile page.
Summary for 009218
Tradename:COUMADIN
Applicant:Bristol Myers Squibb
Ingredient:warfarin sodium
Patents:0
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details
Pharmacology for NDA: 009218
Mechanism of ActionVitamin K Inhibitors
Suppliers and Packaging for NDA: 009218
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
COUMADIN warfarin sodium INJECTABLE;INJECTION 009218 NDA Bristol-Myers Squibb Pharma Company 0056-0168 0056-0168-70 1 BOTTLE in 1 CARTON (0056-0168-70) > 100 TABLET in 1 BOTTLE
COUMADIN warfarin sodium INJECTABLE;INJECTION 009218 NDA Bristol-Myers Squibb Pharma Company 0056-0168 0056-0168-01 10 TABLET in 1 BLISTER PACK (0056-0168-01)

Profile for product number 005

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 007

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 012

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength75MG/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Accenture
Daiichi Sankyo
Cerilliant
Fish and Richardson
Argus Health
Baxter
McKinsey
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot